18F-FDG PET/CT in Diagnostic Patients of Disorder of Consciousness
NCT02999490 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2018-04-20
Summary
Clinical examinations are difficult to discriminate between vegetative state and minimally conscious state. the diagnostic and prognostic usefulness of neuroimaging methods has not been established in a clinical setting. we will do a forward study of PET imaging in disorders of consciousness patients, and validate with clinical assessments with the coma recovery Scale-Revised(CRS-R).
Conditions
- Persistent Vegetative State
Interventions
- RADIATION
-
18F-FDG
18F-FDG is positron emission tomography imaging agent which is already widely used in PET/CT examination.
Sponsors & Collaborators
-
Guangzhou General Hospital of Guangzhou Military Command
lead OTHER
Principal Investigators
-
Yin Jilin
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 10 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2017-12-01
- Completion
- 2017-12-05
Countries
- China
Study Locations
More Related Trials
-
Risk of Developing Dementia and Associated Factors in Patients With Normal Brain FDG PET
NCT04804722 ·Status: COMPLETED
-
Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )
NCT02686216 ·Status: COMPLETED ·Phase: PHASE1
-
Multimodal Resonance Imaging for Outcome Prediction on Coma Patients
NCT00577954 ·Status: COMPLETED
-
Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
NCT02640092 ·Status: COMPLETED ·Phase: PHASE1
-
[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)
NCT02562989 ·Status: COMPLETED ·Phase: PHASE1
-
Combined Whole-brain Structural and Functional MRI for the Prediction of Neurological Recovery After Cardiac Arrest
NCT06617377 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism
NCT02059733 ·Status: COMPLETED ·Phase: PHASE2
-
18F-DPA-714 PET/MR in Dysfunctional Brain Diseases
NCT06851143 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Value of Multimodal MR Imaging in Cognitive Assessment of Patients With Moderate Traumatic Brain Injury
NCT06099210 ·Status: RECRUITING
-
Application of Multi-probe PET/MR Imaging in the Diagnosis and Evaluation of Alzheimer's Disease
NCT05003830 ·Status: UNKNOWN
-
Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease
NCT04926272 ·Status: UNKNOWN ·Phase: PHASE2
-
Early Detection of Mild Cognitive Impairment in Individual Patients
NCT00243451 ·Status: COMPLETED
-
Improving Awakening Prognostication After Non Anoxic Coma Using PET-MRI in Intensive Care Unit
NCT02798588 ·Status: COMPLETED ·Phase: NA
-
Imaging of the Neural Correlates of Arousal and Awareness
NCT04575454 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001362 ·Status: COMPLETED
-
Isotopic Imaging for Prodromal Alzheimer's Disease
NCT01231295 ·Status: COMPLETED
-
[18F]NIDF PET Imaging in Tau-related Diseases
NCT07306598 ·Status: RECRUITING
-
Study of Cerebral Glucose Metabolism in Healthy Volunteers Using 18 F-FDG PET: Evaluation of the Effects of Aging, Comparative Evaluation of Neurodegenerative and Psychiatric Pathologies.
NCT06164938 ·Status: COMPLETED
-
Long-term Cognitive and Cerebral Changes in Sepsis Survivors and Their Predictors
NCT02339649 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study of the Use of a Portable Cranial Scanner in Intensive Care for Cerebro-injured Patients
NCT05891522 ·Status: COMPLETED ·Phase: NA
-
Functional Neuroimaging and Genetic Vulnerability to Suicidal Behavior
NCT02960191 ·Status: TERMINATED ·Phase: NA
-
PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)
NCT02062099 ·Status: COMPLETED ·Phase: PHASE1
-
Modelling in the Quantitative Analysis of Brain PET Scans in Patients With Alzheimer's Disease
NCT04718207 ·Status: COMPLETED
-
Rapid Diagnosis and Prognosis Recognition of Imaging and Biomarkers in Mild to Moderate Traumatic Brain Injury
NCT05108909 ·Status: UNKNOWN
-
PET Changes in Alzheimer's Disease (AD)
NCT00094913 ·Status: UNKNOWN